These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 20422415

  • 1. The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms.
    Trifa AP, Cucuianu A, Petrov L, Urian L, Militaru MS, Dima D, Pop IV, Popp RA.
    Ann Hematol; 2010 Oct; 89(10):979-83. PubMed ID: 20422415
    [Abstract] [Full Text] [Related]

  • 2. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
    Larsen TS, Pallisgaard N, Møller MB, Hasselbalch HC.
    Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
    [Abstract] [Full Text] [Related]

  • 3. JAK2 46/1 haplotype is associated with JAK2 V617F--positive myeloproliferative neoplasms in Brazilian patients.
    Macedo LC, Santos BC, Pagliarini-e-Silva S, Pagnano KB, Rodrigues C, Quintero FC, Ferreira ME, Baraldi EC, Ambrosio-Albuquerque EP, Sell AM, Visentainer JE.
    Int J Lab Hematol; 2015 Oct; 37(5):654-60. PubMed ID: 25959311
    [Abstract] [Full Text] [Related]

  • 4. The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.
    Ohyashiki JH, Yoneta M, Hisatomi H, Iwabuchi T, Umezu T, Ohyashiki K.
    BMC Med Genet; 2012 Jan 17; 13():6. PubMed ID: 22251709
    [Abstract] [Full Text] [Related]

  • 5. The association of the JAK2 46/1 haplotype with non-splanchnic venous thrombosis.
    Zerjavic K, Zagradisnik B, Lokar L, Krasevac MG, Vokac NK.
    Thromb Res; 2013 Aug 17; 132(2):e86-93. PubMed ID: 23845539
    [Abstract] [Full Text] [Related]

  • 6. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.
    Orv Hetil; 2006 Nov 12; 147(45):2175-9. PubMed ID: 17402211
    [Abstract] [Full Text] [Related]

  • 7. JAK2 rs10974944 is associated with both V617F-positive and negative myeloproliferative neoplasms in a Vietnamese population: A potential genetic marker.
    Ngoc NT, Hau BB, Vuong NB, Xuan NT.
    Mol Genet Genomic Med; 2022 Oct 12; 10(10):e2044. PubMed ID: 35996819
    [Abstract] [Full Text] [Related]

  • 8. [Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders].
    Zhang Y, Li L, Nie L, Yu Y, Yang YH, Zhang ZQ, Yang L, Xu SC, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb 12; 29(2):105-9. PubMed ID: 18681311
    [Abstract] [Full Text] [Related]

  • 9. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
    Trifa AP, Bănescu C, Tevet M, Bojan A, Dima D, Urian L, Török-Vistai T, Popov VM, Zdrenghea M, Petrov L, Vasilache A, Murat M, Georgescu D, Popescu M, Pătrinoiu O, Balea M, Costache R, Coleș E, Șaguna C, Berbec N, Vlădăreanu AM, Mihăilă RG, Bumbea H, Cucuianu A, Popp RA.
    Br J Haematol; 2016 Jul 12; 174(2):218-26. PubMed ID: 27061303
    [Abstract] [Full Text] [Related]

  • 10. JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets.
    Toyama K, Karasawa M, Yamane A, Irisawa H, Yokohama A, Saitoh T, Handa H, Matsushima T, Sawamura M, Miyawaki S, Murakami H, Nojima Y, Tsukamoto N.
    Br J Haematol; 2007 Oct 12; 139(1):64-9. PubMed ID: 17854308
    [Abstract] [Full Text] [Related]

  • 11. JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms.
    Oh ST, Gotlib J.
    Expert Rev Hematol; 2010 Jun 12; 3(3):323-37. PubMed ID: 21082983
    [Abstract] [Full Text] [Related]

  • 12. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K, Bock O, Theophile K, von Neuhoff N, Buhr T, Schlué J, Büsche G, Kreipe H.
    Exp Hematol; 2009 Oct 12; 37(10):1186-1193.e7. PubMed ID: 19616600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients.
    Paes JF, Torres DG, Aquino DC, Alves EVB, Mesquita EA, Sousa MA, Fraiji NA, Passos LNM, Abreu RS, Silva GAV, Tarragô AM, de Souza Mourão LP.
    Sci Rep; 2024 Apr 24; 14(1):9389. PubMed ID: 38654055
    [Abstract] [Full Text] [Related]

  • 17. JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms.
    Pietra D, Casetti I, Da Vià MC, Elena C, Milanesi C, Rumi E.
    Am J Hematol; 2012 Jul 24; 87(7):746-7. PubMed ID: 22565617
    [Abstract] [Full Text] [Related]

  • 18. JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients.
    Tanaka M, Yujiri T, Ito S, Okayama N, Takahashi T, Shinohara K, Azuno Y, Nawata R, Hinoda Y, Tanizawa Y.
    Int J Hematol; 2013 Mar 24; 97(3):409-13. PubMed ID: 23430670
    [Abstract] [Full Text] [Related]

  • 19. The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders.
    Larsen TS, Christensen JH, Hasselbalch HC, Pallisgaard N.
    Br J Haematol; 2007 Mar 24; 136(5):745-51. PubMed ID: 17313377
    [Abstract] [Full Text] [Related]

  • 20. JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil.
    da Silva RR, Domingues Hatzlhofer BL, Machado CG, Lima AS, de Albuquerque DM, dos Santos MN, Fertrin KY, Costa FF, Araújo Ada S, Bezerra MA.
    Genet Test Mol Biomarkers; 2012 Jul 24; 16(7):802-5. PubMed ID: 22304488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.